CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,744,913 | +17.0% | 504,493 | -4.4% | 0.01% | +25.0% |
| Q2 2023 | $11,743,574 | -7.5% | 527,801 | -10.0% | 0.01% | -11.1% |
| Q1 2023 | $12,698,370 | +4.1% | 586,259 | -2.4% | 0.01% | 0.0% |
| Q4 2022 | $12,203,284 | -22.2% | 600,851 | -1.8% | 0.01% | -25.0% |
| Q3 2022 | $15,684,000 | +0.3% | 611,715 | -7.0% | 0.01% | 0.0% |
| Q2 2022 | $15,640,000 | +7.7% | 657,667 | +2.0% | 0.01% | +33.3% |
| Q1 2022 | $14,527,000 | +13.1% | 645,074 | -0.6% | 0.01% | +12.5% |
| Q4 2021 | $12,844,000 | -10.8% | 648,709 | -11.3% | 0.01% | -11.1% |
| Q3 2021 | $14,396,000 | -11.8% | 731,524 | -1.3% | 0.01% | -18.2% |
| Q2 2021 | $16,313,000 | -8.1% | 741,517 | -0.7% | 0.01% | -8.3% |
| Q1 2021 | $17,757,000 | -8.8% | 746,416 | +0.3% | 0.01% | -14.3% |
| Q4 2020 | $19,464,000 | +47.5% | 744,016 | -1.9% | 0.01% | +27.3% |
| Q3 2020 | $13,200,000 | -0.2% | 758,399 | -3.5% | 0.01% | -8.3% |
| Q2 2020 | $13,224,000 | +39.5% | 786,215 | -1.4% | 0.01% | +20.0% |
| Q1 2020 | $9,479,000 | -5.4% | 797,253 | -3.8% | 0.01% | +25.0% |
| Q4 2019 | $10,023,000 | -14.1% | 828,376 | +0.4% | 0.01% | -20.0% |
| Q3 2019 | $11,664,000 | +24.8% | 825,234 | -1.6% | 0.01% | +25.0% |
| Q2 2019 | $9,347,000 | -11.6% | 838,282 | -6.9% | 0.01% | -20.0% |
| Q1 2019 | $10,574,000 | -13.5% | 900,618 | -1.6% | 0.01% | -23.1% |
| Q4 2018 | $12,226,000 | -5.0% | 915,093 | -0.3% | 0.01% | +18.2% |
| Q3 2018 | $12,871,000 | +1.5% | 918,069 | +13.8% | 0.01% | -8.3% |
| Q2 2018 | $12,680,000 | -1.3% | 806,639 | +3.3% | 0.01% | 0.0% |
| Q1 2018 | $12,843,000 | -6.2% | 780,700 | +3.0% | 0.01% | -7.7% |
| Q4 2017 | $13,690,000 | +1732.7% | 758,016 | +1859.1% | 0.01% | +1200.0% |
| Q3 2017 | $747,000 | +42.8% | 38,692 | -12.6% | 0.00% | 0.0% |
| Q2 2017 | $523,000 | +220.9% | 44,291 | +198.5% | 0.00% | – |
| Q1 2017 | $163,000 | +50.9% | 14,840 | 0.0% | 0.00% | – |
| Q4 2016 | $108,000 | +14.9% | 14,840 | +2.7% | 0.00% | – |
| Q3 2016 | $94,000 | +16.0% | 14,447 | -2.9% | 0.00% | – |
| Q2 2016 | $81,000 | +37.3% | 14,878 | +17.5% | 0.00% | – |
| Q1 2016 | $59,000 | +13.5% | 12,660 | +20.9% | 0.00% | – |
| Q4 2015 | $52,000 | +33.3% | 10,472 | 0.0% | 0.00% | – |
| Q3 2015 | $39,000 | -61.8% | 10,472 | -38.5% | 0.00% | – |
| Q2 2015 | $102,000 | +117.0% | 17,038 | +9.8% | 0.00% | – |
| Q4 2014 | $47,000 | -4.1% | 15,521 | -14.9% | 0.00% | – |
| Q3 2014 | $49,000 | -3.9% | 18,248 | 0.0% | 0.00% | – |
| Q2 2014 | $51,000 | -57.1% | 18,248 | -32.9% | 0.00% | – |
| Q1 2014 | $119,000 | +190.2% | 27,202 | +4.7% | 0.00% | – |
| Q3 2013 | $41,000 | – | 25,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |